Zoledronic acid is a bisphosphonate that inhibits osteoclastic resorption of bone and calcium release induced by tumour cytokines.

Zoledronic acid is a bisphosphonate  that inhibits osteoclastic resorption of bone and calcium release induced by tumour cytokines. Zoleget is an integral part of the treatment of Multiple Myeloma which causes hypercalcemia associated with osteolytic and osteoporotic bone lesions. Zoledronic acid should not be infused over less than 15 minutes because more rapid infusion may cause renal tubular damage.

 

Indications:

  • Hypercalcemia of Malignancy
  • Multiple Myeloma and Bone Metastases of Solid Tumors

 

Generic Name

Strength

Standard

Type

Packing

Pack Size

Zoledronic Acid

4 mg

IP

INJ

Vial (Combipack)

10 ml